The spin-off company from Vall d’Hebron Institute of Research (VHIR) D-Sight, both members of CATALONIA.HEALTH, has been awarded with the Disruptive Innovation Award at the 18^th edition of the EmprendeXXI Awards. This award is an initiative by Enisa and CaixaBank that award Spanish and Portuguese companies that offer the best solutions in the field of social impact, sustainability, disruptive innovation, scalability, agro and fintech promotion.

This recognition boosts D-Sight’s mission of bringing to the market their innovative drug, which treats the diabetic retinopathy through innovative and non-invasive solutions.

Sources of the company have extended their gratitude to their team for their tireless effort, as well as to the collaborators, investors and the medical community that trusts in the vision of D-Sight: “This award is a reflection of the joint work, and the trust placed in our project”.